Crosstalk between adenosine A1 and β1-adrenergic receptors regulates translocation of PKCε in isolated rat cardiomyocytes

Journal of Cellular Physiology

Volumn 227, Issue 9, 2012, Pages 3201-3207

  Komatsu, Satoshi ^a   Dobson, James G ^a   Ikebe, Mitsuo ^a   Shea, Lynne G ^a   Fenton, Richard A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; FORSKOLIN; ISOPRENALINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE C EPSILON; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; 2 CHLORO N(6)CYCLOPENTYLADENOSINE; 2-CHLORO-N(6)CYCLOPENTYLADENOSINE; ADENOSINE; ADENOSINE A1 RECEPTOR ANTAGONIST; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE; DRUG DERIVATIVE; ISOQUINOLINE DERIVATIVE; MEMBRANE PROTEIN; N (2 (4 BROMOCINNAMYLAMINO)ETHYL) 5 ISOQUINOLINESULFONAMIDE; N-(2-(4-BROMOCINNAMYLAMINO)ETHYL)-5-ISOQUINOLINESULFONAMIDE; PROTEIN KINASE INHIBITOR; PROTEIN KINASE MODULATOR; RACK2 PROTEIN, RAT; SIGNAL PEPTIDE; SULFONAMIDE; XANTHINE DERIVATIVE;

ANIMAL CELL; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; ENZYME LOCALIZATION; ENZYME REGULATION; HEART MUSCLE CELL; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; TRANSVERSE TUBULAR SYSTEM; WESTERN BLOTTING; ANIMAL; CYTOLOGY; DRUG EFFECT; GENETICS; HEART MUSCLE; METABOLISM; ORGAN CULTURE TECHNIQUE; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

RATTUS;

ADENOSINE; ADENOSINE A1 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-1 RECEPTOR AGONISTS; ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FORSKOLIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOPROTERENOL; ISOQUINOLINES; MEMBRANE PROTEINS; MYOCARDIUM; MYOCYTES, CARDIAC; ORGAN CULTURE TECHNIQUES; PROTEIN KINASE C-EPSILON; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1; RECEPTORS, ADRENERGIC, BETA-1; SIGNAL TRANSDUCTION; SULFONAMIDES; XANTHINES;

EID: 84862062788     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24008     Document Type: Article

References (39)

1. Csukai M, Chen C-H, DeMatteis MA, Mochly-Rosen D. 1997. The coatomer protein β'COP: A selective binding protein (RACK) for epsilon protein kinase C. J Biol Chem 272: 29200-29206.
2. Disatnik M-H, Buraggi G, Mochly-Rosen D. 1994. Localization of protein kinase C isozymes in cardiac myocytes. Exp Cell Res 210: 287-297.
3. Dobson JG Jr. 1978. Reduction by adenosine of the isoproterenol-induced increase in cyclic adenosine 3', 5'-monophosphate formation and glycogen phosphorylase activity in rat heart muscle. Circ Res 43: 785-792.
4. Dobson JG, Jr. 1983a. Adenosine reduces catecholamine contractile responses in oxygenated and hypoxic atria. Am J Physiol 245: H468-H474.
5. Dobson JG, Jr. 1983b. Mechanism of adenosine inhibition of catecholamine-induced elicited responses in heart. Circ Res 52: 151-160.
6. 2A and β-adrenergic calcium transient and contractile responses in rat ventricular myocytes. Am J Physiol 295: H2364-H2372.
7. Fenton RA, Chung ES. 2001. Chronic ethanol enhances adenosine antiadrenergic actions in the isolated rat heart. Alcohol Clin Exp Res 25: 968-975.
8. Fenton RA, Dobson JG, Jr. 1984. Adenosine and calcium alter adrenergic-induced intact heart protein phosphorylation. Am J Physiol 246: H559-H565.
9. Fenton RA, Dobson JG, Jr. 1987. Measurement by fluorescence of interstitial adenosine levels in normoxic, hypoxic and ischemic perfused rat hearts. Circ Res 60: 177-184.
10. 2A receptor effects on G-protein cycling in β-adrenergic stimulated ventricular membranes. J Cell Physiol 213: 785-792.
11. Fenton RA, Galeckas KJ, Dobson JG, Jr. 1995. Endogenous adenosine reduces depression of cardiac function induced by β-adrenergic stimulation during low flow perfusion. J Mol Cell Cardiol 27: 2373-2383.
12. Fenton RA, Komatsu S, Ikebe M, Shea LG, Dobson JG, Jr. 2009. Adenoprotection of the heart involves phospholipase C-induced activation and translocation of PKCε to RACK2 in adult rat and mouse. Am J Physiol 297: H718-H725.
13. 2+ transients of isoproterenol-stimulated rat ventricular myocytes. Am J Physiol 261: C1107-C1114.
14. 1-receptor-mediated adenoprotection involves phospholipase C, PKC-ε, and p38 MAPK, but not HSP27. Am J Physiol 298: H1671-H1678.
15. Fenton RA, Tsimikas S, Dobson JG, Jr. 1990. Influence of β-adrenergic stimulation and contraction frequency on heart interstitial adenosine. Circ Res 66: 457-468.
16. Ferreira JC, Brum PC, Mochly-Rosen D. 2011. βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure. J Mol Cell Cardiol 51: 479-481.
17. ε and protein kinase A. J Mol Cell Cardiol 43: 686-695.
18. Hug H, Sarre TF. 1993. Protein kinase C isoenzymes: Divergence in signal transduction? Biochem J 291: 329-343.
19. Komatsu S, Ikebe M. 2004. ZIP kinase is responsible for the phosphorylation of myosin II and necessary for cell motility in mammalian fibroblasts. J Cell Biol 165: 243-254.
20. Komatsu S, Miyazaki K, Tuft RA, Ikebe M. 2002. Translocation of telokin by cGMP signaling in smooth muscle cells. Am J Physiol 283: C752-C761.
21. Komatsu S, Yano T, Shibata M, Tuft RA, Ikebe M. 2000. Effects of the regulatory light chain phosphorylation of myosin II on mitosis and cytokinesis of mammalian cells. J Biol Chem 275: 34512-34520.
22. 1 receptor mediates late preconditioning via activation of PKC-δ signaling pathway. Am J Physiol 283: H296-H301.
23. o, and N-type calcium channel complex at a presynaptic nerve terminal: Analysis by quantitative immunocolocalization. J Neurosci 24: 4070-4081.
24. Miyazaki K, Komatsu S, Ikebe M, Fenton RA, Dobson JG, Jr. 2004. Protein kinase C epsilon and the antiadrenergic action of adenosine in rat ventricular myocytes. Am J Physiol 287: H1721-H1729.
25. Mochly-Rosen D, Henrich CJ, Cheever L, Khaner H, Simpson PC. 1990. A protein kinase C isozyme is translocated to cytoskeletal elements on activation. Cell Regulation 1: 693-706.
26. Mochly-Rosen D, Wu G, Hahn H, Osinska H, Liron T, Lorenz JN, Yatani A, Robbins J, Dorn GW, II. 2000. Cardiotrophic effects of protein kinase Cε. Analysis by In Vivo modulation of PKCε translocation. Circ Res 86: 1173-1179.
27. Palaniyandi SS, Sun L, Ferreira JCB, Mochly-Rosen D. 2009. Protein kinase C i heart failure: A therapeutic target? Cardiovasc Res 82: 229-239.
28. Perlini S, Khoury E, Norton GR, Chung ES, Fenton RA, Dobson JG, Jr, Meyer TE. 1998. Adenosine mediates sustained antiadrenergic depression via activation of protein kinase C in the rat heart. Circ Res 83: 761-771.
29. Robia SL, Kang M, Walker JW. 2005. Novel determinant of PKC-ε anchoring at cardiac Z-lines. Am J Physiol 289: H1941-H1950.
30. Romano FD, Dobson JG, Jr. 1990. Adenosine modulates β-adrenergic signal transduction in guinea pig heart ventricular membranes. J Mol Cell Cardiol 22: 1359-1370.
31. Romano FD, MacDonald SG, Dobson JG, Jr. 1989. Adenosine receptor coupling to adenylate cyclase of rat ventricular myocyte membranes. Am J Physiol 257: H1088-H1095.
32. Rona G. 1985. Catecholamine cardiotoxicity. J Mol Cell Cardiol 17: 291-306.
33. Rybin VO, Steinberg SF. 1994. Protein kinase C isoform expression and regulation in the developing rat heart. Circ Res 74: 299-309.
34. 1 receptor activation is abolished by protein kinase C inhibitors in the rabbit. Cardiovasc Res 29: 682-688.
35. Schomig A. 1990. Catecholamines in myocardial ischemia: Systemic and cardiac release. Circulation 82: II-13-II-22.
36. Schomig A, Haass M, Richardt G. 1991. Catecholamine release and arrhythmias in acute myocardial ischemia. Eur Heart J 124: F38-F47.
37. Schrader J, Baumann G, Gerlach E. 1977. Adenosine as inhibitor of myocardial effects of catecholamines. Pflugers Arch 372: 29-35.
38. Sheff D, Lowe M, Kreis TE, Mellman I. 1996. Biochemical Heterogeneity and Phosphorylation of Coatomer Subunits. J Biol Chem 271: 7230-7236.
39. Yao L, Fan P, Jiang Z, Gordon A, Mochly-Rosen D, Diamond I. 2008. Dopamine and ethanol cause translocation of εPKC associated with εRACK: Cross-talk between cAMP-dependent protein kinase A and protein kinase C signaling pathways. Mol Pharmacol 73: 1105-1112.